ZBH Zimmer Biomet Holdings, Inc.
Healthcare$84.50+0.00%OpenMarket Cap: $16.35B
As of 2026-05-26
Valuation
P/E (TTM)
25.69
PEG
—
P/B
1.13
P/S
1.97
EV/EBITDA
10.69
DCF Value
$483.36
FCF Yield
11.1%
Div Yield
1.1%
Margins & Returns
Gross Margin
70.0%
Operating Margin
15.6%
Net Margin
9.1%
ROE
5.8%
ROA
3.4%
ROIC
5.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.09B | 72.4% | $373.2M | $238.1M | $— | $0.48 |
| Q4 null | $2.24B | 64.7% | $287.8M | $139.5M | $— | $0.48 |
| FY null | $8.23B | 61.6% | $1.36B | $705.2M | $— | $1.20 |
| Q3 null | $2.00B | 72.1% | $351.3M | $230.9M | $— | $0.24 |
| Q2 null | $2.08B | 71.5% | $300.0M | $152.8M | $— | $0.48 |
| Q1 null | $1.91B | 71.2% | $292.3M | $182.0M | $— | $0.48 |
| Q4 null | $2.02B | 71.0% | $389.0M | $239.5M | $— | $0.48 |
| FY null | $7.68B | 71.5% | $1.29B | $903.8M | $— | $0.96 |
| Q3 null | $1.82B | 70.5% | $279.5M | $249.1M | $— | $0.24 |
| Q2 null | $1.94B | 71.5% | $351.3M | $242.8M | $— | $0.48 |
| Q1 null | $1.89B | 72.9% | $265.9M | $172.4M | $— | $0.24 |
| Q4 2023 | $1.94B | 72.2% | $354.2M | $419.2M | $2.01 | $0.48 |